The polypeptide of aa 130 -230 of the G protein (G2Na) of respiratory syncytial virus (RSV) was fused to BB, the albumin-binding region of streptococcal G protein, producing BBG2Na, which induced protective immune responses in rodent models. Evaluation of the immune response in mice immunized with BBG2Na in the adjuvant alhydrogel revealed high amounts of interleukin (IL)-5 and some IL-4 in splenocytes restimulated in vitro. This is compatible with a Th2 response. The activation of the Th2 pathway in such mice was further supported by the detection of IL-5 and G2Na-specific IgE in vivo. Of interest, in contrast to immunization with formalin-inactivated RSV, immunization of mice with BBG2Na followed by intranasal RSV challenge did not lead to increased production of IL-5 -or G2Na-specific IgE. However, IgG1-and IgG2a-specific antibodies were boosted. These results demonstrate that the Th2 pathway is not enhanced by RSV challenge in BBG2Na-immunized mice.
Respiratory syncytial virus (RSV) is the most important
However, the isolation of CD4 / T cell lines specific for the G protein suggests that at least one Th cell epitope is expressed cause of bronchiolitis and viral pneumonia in infants and young on this protein [12, 13] . This protein, either pure [10, 14, 15] children. Efforts to develop live attenuated or inactivated vacor expressed in vaccinia virus vector [9] , has been reported to cines have been unsuccessful. In the 1960s, children vaccinated modulate the immune response via the Th2 pathway and to with a formalin-inactivated RSV vaccine (FI-RSV) developed lead to immunopathology upon challenge [14] . enhanced disease after subsequent natural infection. Attempts
In 1991, Trudel et al. [16] demonstrated that the peptide to elucidate the immunologic mechanisms responsible for the comprising aa 174 -187 of the G protein coupled to KLH could aberrant disease supported the notion that type 2 helper T (Th2) induce protective immune responses in mice [16] . The central cells were involved [1] . These cells, expressing the CD4 molehydrophobic region of the G protein of RSV (amino acid resicule, can secrete interleukin (IL)-4, IL-5, and IL-10. They differ dues 124 -203), including aa 174 -187, protected mice chalfrom the type 1 helper T (Th1) cells, which strongly secrete lenged with RSV [17] . We recently described the construction IL-2 and interferon (IFN)-g [2, 3]. After immunization with and prokaryotic expression of a recombinant RSV subunit vac-FI-RSV and challenge with RSV, typical Th2 cytokine produccine [18] currently designated BBG2Na. This fusion protein tion was further enhanced and led to an increase in granulocomprised residues 130 -230 of the RSV G protein (G2Na) cytes, eosinophils, and CD4
/ cells in mice [4] . Depletions in and the albumin-binding domain (BB) of streptococcal G pro-CD4
/ cells in FI-RSV -immunized mice abrogated pulmonary tein. BB was selected as a fusion partner because it increased histopathology induced by RSV challenge [5] .
the in vivo half-life of model proteins in rodents [19] and RSV has two major surface glycoproteins: the attachment nonhuman primates [20] . Furthermore, BB exhibited carrierprotein G and the fusion protein F. Both proteins induced prorelated properties, since antibody responses to fused peptides tection of BALB/c mice challenged with RSV. Several B epiwere significantly enhanced [21] . Efficacy of BBG2Na in protopes were identified on the F and G proteins [6] , and a T cell tecting mice and cotton rats was tested: When injected, the epitope was identified on the F protein [7] . Splenocytes from molecule conferred protection against RSV challenge [22] . mice immunized with the F protein secreted IL-2 and IFN-g, Since the experience with FI-RSV had inevitably created typical Th1 cytokines [8 -10] . However, vaccine formulation concern about safety of all RSV vaccines, it must be demonand route of delivery can influence the pattern of cytokine strated that BBG2Na is safe and does not induce immunopotenexpression in the lungs of mice primed with the F protein [11] .
tiation of the Th2 response. The aim of the present study was So far, no T cell epitope has been identified on the G protein.
to characterize the cytokine pattern of mice immunized with BBG2Na and to evaluate the influence of an RSV challenge. IL-5 and IgE, two markers of the Th2 pathway, were followed protein purification of BBG2Na and G2Na were undertaken as duplicate by ELISA (Genzyme, Cambridge, MA [for IL-2 and previously described [19, 23] . After being freeze-dried, proteins IFN-g] and Endogen, Woburn, MA [for IL-4 and IL-5]) following were further purified to homogeneity by reversed-phase high-perthe manufacturer's instructions. formance liquid chromatography on a preparative C4 column (VyDetermination of cytokines in vivo. Groups of 5 mice were dak, Hesperice, CA; 250 1 22 mm internal diameter, 300 Å , 10 immunized twice, 14 days apart, with intramuscular (im) injections mm) with a triethylammonium formate buffer (TEAF)-acetonitrile of BBG2Na (20 mg/mouse), FI-RSV (0.5 mg), or PBS (as control) gradient, using 40 mM TEAF (pH 3.0; solvent A) and a mixture in alhydrogel (20% vol/vol). At 3, 6, 9, 12, 24, and 48 h after the of 40 mM TEAF (pH 3.0)-acetonitrile (10:90; solvent B). The last immunization, some groups were sacrificed, and sera were flow rate was 8 mL/min, and the gradient consisted of a 0-to 37.5-collected by intracardiac puncture for cytokine measurements. The mm linear gradient from 5% to 80% solvent B (2%/min). Fractions other groups were challenged by intranasal (inl) instillation of RSV were collected for analysis by SDS-PAGE. G2Na and BBG2Na
(10 5 TCID 50 /mL) or BBG2Na (10 mg) mixed with 10 mg of subunit containing fractions were pooled individually and freeze-dried.
B of cholera toxin (CTB; Sigma). Sera were collected 3, 6, 9, 12, Protein content was determined by the bicinchoninic acid method, 24 , and 48 h after challenge for cytokine measurements. IL-5 and and proteins were analyzed for purity by SDS-PAGE in a 15% IFN-g determinations were done as described above. homogeneous gel under reducing conditions. Cultures mg BBG2Na mixed with 10 mg CTB (BBG2Na-CTB). Sera were were harvested onto filters, using a semi-automatic harvester (Skacollected for determination of G2Na-specific IgE, IgG1, and IgG2a tron, Lier, Norway), and the incorporated [ 3 H]thymidine was deterisotypes. mined using a beta counter 1900CA-Tricarb; Packard Instruments, For BAL, mice were sacrificed, and blood was collected by Meriden, CT). Results were expressed in counts per minute (cpm) cardiac puncture. BAL was performed through a catheter inserted and were calculated from the geometric means of triplicate culinto the trachea and by flushing the lungs once with 0.8 mL of tures. Stimulation indices were calculated as cpm experimental /cpm basal .
PBS. BAL fluid was centrifuged, and the supernatant was stored For depletion experiments, 50 1 10 6 cells were incubated with at 020ЊC for isotype determinations. For this purpose, 96-well either biotinylated anti-CD4 or -CD8 (PharMingen, San Diego) plates (Immulon-2; Dynatech, Chantilly, VA) were coated by overantibodies for 30 min at room temperature. After a further incubanight incubation at 4ЊC with G2Na (5 mg/mL). For standard curves, tion with 10 mg/mL magnetic beads coupled to streptavidin (Dyplates were incubated with goat anti-IgG1 (Southern Biotechnolnal, Oslo), cells were passed through a magnetic column to remove ogy, Birmingham, AL), goat anti-IgG2a (Southern Biotechnology), CD4
/ or CD8 / T cell populations. Efficacy of the depletion was or goat anti-IgE (PharMingen). Plates were then washed three assessed by flow cytometry.
times with PBS, and nonspecific binding was blocked by saturation Determination of cytokines in vitro. Six-week-old pathogenwith 0.5% gelatin for 1 h at 37ЊC. Plates were washed three more free BALB/c mice (IFFA CREDO) were used for the experiments.
times with PBS. Serial dilutions of sera to be tested or immunoGroups of 5 mice were immunized by intraperitoneal (ip) injection globulin standards were added to the wells, which were incubated of G2Na (15 mg/mouse), BBG2Na (50 mg/mouse), or PBS in for 1.5 h at 37ЊC. After being washed three times in PBS, horseradalhydrogel (20% vol/vol; Superfos Biosector, Vedbaek, Denmark).
ish peroxidase-conjugated goat anti-mouse IgG1 and IgG2a Ten days after immunization, spleens were removed and perfused (Southern Biotechnology) were added to each well for 1 h at 37ЊC. with RPMI 1640. Spleen cells were pooled within experimental For IgE determination, plates were incubated with biotinylated groups, washed, and resuspended in RPMI 1640 containing 1% goat anti-mouse IgE (PharMingen) for 1 h at 37ЊC, followed by fetal calf serum (Costar, Brumath, France), 1% glutamine (Gibco), incubation with avidin-peroxidase (Sigma) for 30 min. After 3 and antibiotics (50 IU/mL; Gibco). Cells were restimulated in vitro washes, 100 mL of TMB (3,3,5,5-tetramethyl benzidine, dihydroby incubating 5 1 10 5 cells/mL in 96-well round-bottom plates chloride; Pierce, Rockford, IL), as substrate for the peroxidase, (Costar) in triplicate with various concentrations of G2Na or was added to each well. The reaction was stopped 10 min later BBG2Na. Cultures were incubated for 48 h (for IL-2 and IFN-g by the addition of 1 M H 2 SO 4 . Optical density was measured at detection) or for 96 h (for IL-4 and IL-5 detection) at 37ЊC in 5% CO 2 . Supernatants were collected and cytokines were measured in 450 nm. located within aa 130 -230 of the G protein of RSV. Since G2Na is fused to BB polypeptide, we studied the T cell proliferation in response to G2Na from BBG2Na-immuResults nized mice. Cells from these mice proliferated in response to G2Na polypeptide expresses a T cell epitope capable of various concentrations of the G2Na molecule ( figure 1B) . A generating T cell clones when fused to BB molecule. To inbetter T cell proliferation was obtained when cells were activestigate whether a T cell epitope was located on G2Na polyvated with various concentrations of BBG2Na ( figure 1B) . No peptide, in vitro proliferation of cells from inguinal lymph proliferation was observed when cells from naive mice were nodes of G2Na-immunized mice was performed in response activated with BBG2Na or G2Na (data not shown). These reto various concentrations of G2Na. Cells proliferated when sults demonstrated that in vivo priming of mice with G2Na or activated with 1 -100 mg/mL G2Na ( figure 1A) . Proliferation BBG2Na could generate CD4-specific Th cell clones. was concentration-dependent and was maximal for 10 mg/mL BBG2Na adjuvanted with alhydrogel orients the immune G2Na. No proliferation of cells from PBS-immunized mice in response via the Th2 pathway. To study further the Th reresponse to G2Na stimulation was observed. To identify which sponse of BBG2Na and especially the cytokine pattern obtained cell population was proliferating in response to G2Na, cells after activation with the BBG2Na molecule, mice were immufrom G2Na-immunized mice were depleted of CD8 / or CD4 cytokines were maximal on day 2 for IL-2 and IFN-g and on Challenge with RSV does not potentiate the Th2 pathway in BBG2Na-immunized mice. Immunopotentiation of the Th2 day 4 for IL-4 and IL-5 (data not shown). Cells from BBG2Na-immunized mice produced increasing levels of IL-5 and some pathway after immunization with FI-RSV was not due to prior immunization with the denatured virus but to the encounter IL-4 in response to increasing concentrations of BBG2Na (figure 2A) . In contrast, they produced low amounts of IL-2 and with RSV. To determine whether an RSV challenge was boosting the Th2 response in BBG2Na-immunized mice, IL-5 con-IFN-g after in vitro activation with BBG2Na ( figure 2B ). These results suggested that the CD4 / T cells generated after centrations in sera from mice immunized with BBG2Na in alhydrogel and challenged with RSV were quantified. These BBG2Na immunization were mostly Th2 cells.
IL-5 concentrations were compared with those obtained after To get an overall view of the cytokine profile obtained after immunization with FI-RSV and RSV challenge. As expected, immunization with BBG2Na in alhydrogel, serum IL-5 and after immunization with FI-RSV, IL-5 production increased IFN-g produced in vivo were measured. After two immunizain a time-dependent manner after the RSV challenge, with a tions, a time-dependent increase in IL-5 production ( figure 3A) maximum of 451 pg/mL at 24 h after challenge ( figure 4A ). was measured and reached 300 pg/mL at 12 h. The levels of No IL-5 production was detected in PBS-immunized mice. IL-5 detected in sera from BBG2Na-immunized mice were higher than those obtained after immunization of mice with After BBG2Na immunization of mice and challenge by inl administration of BBG2Na in CTB, IL-5 production was in-FI-RSV ( figure 3A) . A time-dependent increase in IL-5 production was nonetheless observed after 2 immunizations with FIcreased in a time-dependent manner, with a maximal production of 121 pg/mL at 12 h after challenge ( figure 4B ). This RSV, reaching a maximum of 60 pg/mL at 12 h. In agreement with a Th2 response, no IFN-g was detected when mice were increase was lower than that obtained after immunization with FI-RSV and RSV challenge. No IL-5 was detected in nonimimmunized with BBG2Na ( figure 3B ) or with FI-RSV (figure 3B). No cytokine was detected in PBS-immunized mice (data munized mice challenged with BBG2Na in CTB ( figure 4B ). Of interest, in contrast to what was observed with FI-RSV not shown). Similar results were obtained when mice were immunized by the subcutaneous (sc) route (data not shown).
immunization, no IL-5 production could be measured when mice were immunized with BBG2Na in alhydrogel and further These results confirmed that the Th2 pathway was triggered after immunization with BBG2Na in alhydrogel. when mice were immunized sc with BBG2Na (data not shown).
level of G2Na-specific IgE did not increase 5 and 7 days after the RSV challenge (figure 5A), and none was detected later An increase in IFN-g was not observed in any of the cases (data not shown). In another set of experiments, IL-10 was (data not shown). Similar results were observed after immunization with 3 mg of BBG2Na and after sc and ip immunization. measured. Low amounts of IL-10 were detected after immunization with BBG2Na. The RSV challenge did not increase However, higher amounts of IgE were detected after sc immunization with BBG2Na in alhydrogel (data not shown). Immuits level (data not shown). These results showed that after immunization with BBG2Na, the Th2 pathway was not potentinization with BBG2Na also induced a strong production of G2Na-specific IgG1 (200 mg/mL; figure 5B ) and IgG2a (833 ated upon RSV challenge.
To confirm that the Th2 pathway was not enhanced by RSV ng/mL; figure 5C ) before challenge. The G2Na-specific IgG1 level was significantly increased (P õ .05) 5 and 7 days after challenge after immunization with BBG2Na, G2Na-specific IgE was measured. Immunization with BBG2Na induced prochallenge with RSV, reaching 1.5 mg/mL at day 7. In a similar fashion, the G2Na-specific IgG2a response significantly induction of Ç1000 ng/mL G2Na-specific IgE (figure 5A). The / 9d31$$se21 07-24-97 07:57:23 jinfal UC: J Infect reported to correlate with a Th2 profile [26] . In several illnesses, such as allergy [27] and immunologic abnormalities In parallel, serum antibody responses were followed after immunization with BBG2Na and inl boost with BBG2Na in following measles infection [28] , the Th2 orientation of the immune response has been correlated with pathology. In con-CTB. In contrast to what was previously observed (figure 5), an inl boost with BBG2Na in CTB induced a strong increase trast, in certain virus models, such as influenza virus, a Th1 profile is associated with protection [29] . There is evidence in G2Na-specific IgE, reaching 3974 ng/mL 7 days after the inl boost ( figure 6A ). Inl boost with BBG2Na in CTB significantly demonstrating that the G protein, in contrast to the F protein, of RSV modulates the immune response via the Th2 pathway. increased the G2Na-specific IgG1 (figure 6B) and IgG2a ( figure  6C ). In BAL fluids from mice immunized with BBG2Na and Purified G protein or G protein expressed in vaccinia virus induced the production of IL-4 but not IL-2 and IFN-g. Morechallenged by inl instillation of BBG2Na in CTB, both G2Na-specific IgG1 and IgG2a concentrations were increased upon over, it has been reported that adjuvants also modulate the immune response. Alhydrogel is known to orient the immune BBG2Na inl boost (table 1). The boost was detectable 5 days after the inl instillation with BBG2Na adjuvanted in CTB.
response via the Th2 pathway [30] . Unpublished observations indicated that splenocytes from mice immunized ip with No G2Na-specific antibodies were detected in PBS-immunized mice (data not shown).
BBG2Na produced high cytokine levels after in vitro reactivation, compared with levels from mice immunized sc. BBG2Na adjuvanted with alhydrogel modulates toward the Th2 pathway, Discussion since in vitro activation of splenocytes from BBG2Na-immunized mice with BBG2Na induced IL-4 and IL-5 production Several reports have indicated that the F protein can elicit a Th cell response and is the major antigen recognized by with almost no IL-2 and IFN-g. It has been reported that the lymphoid tissue microenvironment exerts regulatory influences murine virus-specific Th cells [1] . The identification of a T cell epitope on the F protein of RSV has been reported [7] . In over cytokine production by T cells [31] . Moreover, compartmentalization of antigen-driven cytokine responses have been the present report, we demonstrated a Th cell epitope on aa 130 -230 of the G protein of RSV: Cells from inguinal lymph described [32] .
To overcome these problems, we measured production of nodes of G2Na-immunized mice proliferated when reactivated in vitro with G2Na. Moreover, an important reduction in the cytokine as already published [33] . Immunization by the im route was used for the in vivo studies in order to mimic the proliferation was obtained after depletion in CD4
/ cells in response to G2Na polypeptide, demonstrating that the CD4 route of administration that would be used for humans. Serum detection of cytokines confirmed that immunization with cells are responsible for the proliferation observed after activation with BBG2Na. The residual proliferation might be due to BBG2Na induced a Th2 profile of cytokines: A high production of IL-5 but no IFN-g was detected several hours after BBG2Na contaminant CD4 T cells undetected in flow cytometry controls. B cell proliferation in response to BBG2Na can not be immunization. Additional proof of Th2 orientation came from the anti-G2Na isotype profile obtained after immunization: High levels of anti-G2Na IgG1 and some anti-G2Na IgE was an RSV challenge led to immunopotentiation of the Th2 pathway, since a time-dependent increase in serum IL-5 was obdetected, confirming that the BBG2Na response was oriented toward Th2. Since adjuvants may modulate the Th1/Th2 balserved. In a similar fashion, the IgE level increased upon RSV challenge (data not shown). It was important to make sure that ance [34] , further studies will determine the cytokine profiles after immunization with BBG2Na in alternative adjuvants.
we had an experimental model in which the inl boost with BBG2Na-CTB following im immunization with BBG2Na in Several reports support the idea that immunopathology observed after FI-RSV vaccination was due to an immunopotentialhydrogel was reactivating the immune system. In BBG2Na-immunized mice, levels of IL-5 and G2Na-specific IgE were ation of the Th2 pathway [4, 5] . It was therefore of interest to demonstrate that after BBG2Na immunization and RSV chalraised after inl instillation of BBG2Na, indicating that, indeed, immunization with BBG2Na by the nasal route could recall an lenge, no enhancement of the Th2 pathway was observed. As previously reported, immunization with FI-RSV followed by established BBG2Na-specific immune response and that the / 9d31$$se21 07-24-97 07:57:23 jinfal UC: J Infect
